Pricing Log in Create free account

Elicio Therapeutics, Inc. (ELTX) vs Impact Biomedical Inc. (IBO)

Elicio Therapeutics, Inc. and Impact Biomedical Inc. are both Biotechnology companies. Elicio Therapeutics, Inc. and Impact Biomedical Inc. are of similar size ($38.0M and $37.9M). Impact Biomedical Inc. has the higher net margin (2,254.3% vs 0.00%) and the lower return on invested capital (−22.8% vs 0.00%). Across the 16 metrics below, Impact Biomedical Inc. leads on 9 and Elicio Therapeutics, Inc. on 7.

Valuation

Metric ELTX IBO Biotechnology median
P/E n/m n/m 10.60
P/S 1.01 1,000.83 9.40
P/B 3.69 2.50 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 0.56 1,228.29 9.02
Earnings yield (142.76%) (27.13%) (32.88%)
Free cash flow yield (129.21%) (1.50%) (23.13%)

Profitability

Metric ELTX IBO Biotechnology median
Gross margin 0.00% (1,111.43%) 68.51%
Operating margin 0.00% (14,600.00%) 0.00%
Net margin 0.00% 2,254.29% 0.00%
Free cash flow margin 0.00% (1,451.43%) 0.00%
Return on equity (774.56%) 24.01% (51.96%)
Return on assets (124.36%) 4.41% (46.06%)
Return on invested capital 0.00% (22.81%) 0.00%

Growth

Metric ELTX IBO Biotechnology median
Revenue growth (TTM) 921.02% — 6.76%
EPS growth (last fiscal year) 39.29% 83.48% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ELTX IBO Biotechnology median
Debt to equity 1.20 0.00 0.00
Current ratio 2.77 0.16 4.97
Net debt to EBITDA 0.25 0.00 1.01

Dividend

Metric ELTX IBO Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ELTX IBO Biotechnology median
Market cap 37.93m 38.01m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack